Related Experiment Video
Updated: May 9, 2026

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
Personalized medicine in CLL: current status and future perspectives
Uri Rozovski1, Inbal Hazan-Halevy2, Michael J Keating1
1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Chronic lymphocytic leukemia (CLL) remains largely incurable despite advances. Personalized therapy and early intervention in select patients show promise for improving outcomes in this common blood cancer.
Area of Science:
- Hematology
- Oncology
- Genetics
Background:
- Chronic lymphocytic leukemia (CLL) is a prevalent blood cancer with limited cure rates.
- Current prognostic factors are underutilized, leading to non-personalized treatment strategies.
- Existing treatment guidelines often exclude elderly or "unfit" patients.
Purpose of the Study:
- To highlight the need for personalized therapeutic approaches in CLL.
- To discuss the impact of recent advances in CLL pathobiology and targeted therapies.
- To advocate for early intervention in selected CLL patients.
Main Methods:
- Review of recent advances in CLL pathobiology research.
- Analysis of high-throughput technologies in CLL studies.
- Evaluation of novel targeted therapies for CLL treatment.
Main Results:
- Personalized medicine offers a tailored approach to CLL management.
- Novel targeted therapies demonstrate high efficacy and low toxicity.
- Early intervention in specific patient groups may improve cure rates.
Conclusions:
- Personalized therapeutic strategies are crucial for improving CLL outcomes.
- Advances in targeted therapies are transforming CLL treatment paradigms.
- Early intervention in selected CLL patients could lead to cures.
More Related Videos
10:18From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Treatment Resistent Cancers
Cancer